Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery.
Jorge Arredondo ChavesJ BaixauliC PastorA ChopiteaJ J SolaI GonzálezJ A-CienfuegosP MartínezJ RodriguezJ L Hernández-LizoainPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2016)
Preoperative chemotherapy in LACC patients is safe and able to induce major tumor regression. Survival times are encouraging, and further research seems warranted.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- rectal cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- lymph node
- sentinel lymph node
- patients undergoing
- prostate cancer
- peritoneal dialysis
- radiation therapy
- coronary artery bypass
- acute coronary syndrome
- free survival
- patient reported
- percutaneous coronary intervention